drugset / Trial / NCT05789719

An Exploratory Clinical Study to Investigate the Effect of autoSTEM-OA and alloSTEM-OA in Participants With Knee Osteoarthritis

NCT05789719 ↗

Phase 1 Unknown 20 enrolled StemMedical A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

A phase 1 exploratory clinical study to investigate safety, tolerance and efficacy of a single intra-articular injection of autoSTEM-OA or alloSTEM-OA in participants with mild to moderate knee osteoarthritis

Timeline

Start
2023-11-01
Primary completion
2024-11-01
Completion
2024-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject STEM-OA Cell therapy 4e+08 cells Intravitreal
Subject STEM-OA Cell therapy 8e+08 cells Intravitreal
Subject STEM-OA Cell therapy 1.6e+09 cells Intravitreal

Indications